Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) EBIT (2016 - 2026)

Bioceres Crop Solutions' EBIT history spans 5 years, with the latest figure at -$4.3 million for Q1 2026.

  • On a quarterly basis, EBIT fell 200.0% to -$4.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$10.6 million, a 164.07% decrease, with the full-year FY2025 number at -$2.2 million, down 104.88% from a year prior.
  • EBIT hit -$4.3 million in Q1 2026 for Bioceres Crop Solutions, down from $4.3 million in the prior quarter.
  • Over the last five years, EBIT for BIOX hit a ceiling of $4.3 million in Q1 2025 and a floor of -$8.2 million in Q2 2022.
  • Historically, EBIT has averaged -$2.7 million across 3 years, with a median of -$4.3 million in 2026.
  • Biggest five-year swings in EBIT: tumbled 248.68% in 2022 and later tumbled 200.0% in 2026.
  • Tracing BIOX's EBIT over 3 years: stood at -$8.2 million in 2022, then skyrocketed by 152.34% to $4.3 million in 2025, then tumbled by 200.0% to -$4.3 million in 2026.
  • Business Quant data shows EBIT for BIOX at -$4.3 million in Q1 2026, $4.3 million in Q1 2025, and -$8.2 million in Q2 2022.